Loading...
Loading...

Air Liquide strengthens its position in the medical gases sector

Air Liquide was granted approval to market pharmaceutical product xenon for anesthesia in Germany.

This approval is the key step in the growth strategy of the pharmaceutical activity of Air Liquide.

The approval of the new medical application provides Air Liquide the opportunity to grow in the medical market. Millions of surgical procedures are performed (using general and local anesthetics) every year and therefore the medical market offers great potential for the company.

Xenon for anesthesia is planned to accelerate the further development of xenon applications for patient groups such as pregnant women and small children, for whom there are only a small number of authorised anesthetics available today.

... to continue reading you must be subscribed

Subscribe Today

Paywall Asset Header Graphic

To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.

Please wait...
-->